214 related articles for article (PubMed ID: 8258143)
21. Metabolically active antigen presenting cells are required for human T cell proliferation in response to the superantigen streptococcal M protein.
Tomai MA; Beachey EH; Majumdar G; Kotb M
FEMS Microbiol Immunol; 1992 Feb; 4(3):155-64. PubMed ID: 1575992
[TBL] [Abstract][Full Text] [Related]
22. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins.
Yagi J; Uchiyama T; Janeway CA
J Immunol; 1994 Feb; 152(3):1154-62. PubMed ID: 7905498
[TBL] [Abstract][Full Text] [Related]
23. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
[TBL] [Abstract][Full Text] [Related]
24. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
[TBL] [Abstract][Full Text] [Related]
25. Dissociation of antigen-presenting capacity of astrocytes for peptide-antigens versus superantigens.
Rott O; Tontsch U; Fleischer B
J Immunol; 1993 Jan; 150(1):87-95. PubMed ID: 7678036
[TBL] [Abstract][Full Text] [Related]
26. One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation.
Nisini R; Fattorossi A; Ferlini C; D'Amelio R
Eur J Immunol; 1996 Apr; 26(4):797-803. PubMed ID: 8625970
[TBL] [Abstract][Full Text] [Related]
27. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
Karp DR; Teletski CL; Scholl P; Geha R; Long EO
Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
[TBL] [Abstract][Full Text] [Related]
28. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.
Lando PA; Dohlsten M; Hedlund G; Brodin T; Sansom D; Kalland T
Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257
[TBL] [Abstract][Full Text] [Related]
29. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
30. Viral peptide specific induction of MHC class II expression by murine T cell clones.
Thomas DB; Smith CA; Graham CM
J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
[TBL] [Abstract][Full Text] [Related]
31. Definition of the mitogenic factor (MF) as a novel streptococcal superantigen that is different from streptococcal pyrogenic exotoxins A, B, and C.
Toyosaki T; Yoshioka T; Tsuruta Y; Yutsudo T; Iwasaki M; Suzuki R
Eur J Immunol; 1996 Nov; 26(11):2693-701. PubMed ID: 8921957
[TBL] [Abstract][Full Text] [Related]
32. Clonal heterogeneity of superantigen reactivity in human V beta 6+ T cell clones. Limited contributions of V beta sequence polymorphisms.
Goronzy JJ; Oppitz U; Weyand CM
J Immunol; 1992 Jan; 148(2):604-11. PubMed ID: 1530864
[TBL] [Abstract][Full Text] [Related]
33. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a viral superantigen in humans.
Lafon M; Lafage M; Martinez-Arends A; Ramirez R; Vuillier F; Charron D; Lotteau V; Scott-Algara D
Nature; 1992 Aug; 358(6386):507-10. PubMed ID: 1386410
[TBL] [Abstract][Full Text] [Related]
35. Role of antigen-presenting cells in activation of human T cells by the streptococcal M protein superantigen: requirement for secreted and membrane-associated costimulatory factors.
Majumdar G; Ohnishi H; Tomai MA; Geller AM; Wang B; Dockter ME; Kotb M
Infect Immun; 1993 Feb; 61(2):785-90. PubMed ID: 8423107
[TBL] [Abstract][Full Text] [Related]
36. Bacterial superantigen specificities of mouse T cell receptor V beta 20.
Bravo de Alba Y; Cazenave PA; Marche PN
Eur J Immunol; 1995 Dec; 25(12):3425-30. PubMed ID: 8566033
[TBL] [Abstract][Full Text] [Related]
37. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms.
Uchiyama T; Miyoshi-Akiyama T; Kato H; Fujimaki W; Imanishi K; Yan XJ
J Immunol; 1993 Oct; 151(8):4407-13. PubMed ID: 8409410
[TBL] [Abstract][Full Text] [Related]
38. Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases.
Li ZJ; Omoe K; Shinagawa K; Yagi J; Imanishi K
Microbiol Immunol; 2009 Aug; 53(8):451-9. PubMed ID: 19659929
[TBL] [Abstract][Full Text] [Related]
39. Chemical chaperones enhance superantigen and conventional antigen presentation by HLA-DM-deficient as well as HLA-DM-sufficient antigen-presenting cells and enhance IgG2a production in vivo.
Ghumman B; Bertram EM; Watts TH
J Immunol; 1998 Oct; 161(7):3262-70. PubMed ID: 9759841
[TBL] [Abstract][Full Text] [Related]
40. A lectin-binding, protease-resistant mycobacterial ligand specifically activates V gamma 9+ human gamma delta T cells.
Pfeffer K; Schoel B; Plesnila N; Lipford GB; Kromer S; Deusch K; Wagner H
J Immunol; 1992 Jan; 148(2):575-83. PubMed ID: 1530863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
